Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage

NCT02670824 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Intracerebral Hemorrhage (ICH)

Interventions

DRUG: CN-105
DRUG: Placebo

Sponsor

AegisCN LLC